Lv31
268 积分 2023-12-20 加入
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
3小时前
已完结
Posology, Efficacy, and Safety of Epidermal Growth Factor Eye Drops in 305 Patients: Logistic Regression and Group-Wise Odds of Published Data
16天前
已完结
Persisting Corneal Erosion Under Cetuximab (Erbitux) Treatment (Epidermal Growth Factor Receptor Antibody)
16天前
已完结
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
18天前
已完结
Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye
20天前
已完结
A phase 1 study of ABT-806 in subjects with advanced solid tumors
21天前
已完结
Targeting MET in cancer: rationale and progress
1个月前
已完结
Deinococcus radiodurans — the consummate survivor
1个月前
已完结
T cell engagers in autoimmune diseases
3个月前
已完结
Author Correction: Structural basis of assembly of the human T cell receptor–CD3 complex
3个月前
已完结
皖公网安备34019202002308
